My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 176

    1.

    Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.

    Hermansen K, Colombo M, Storgaard H, ØStergaard A, Kølendorf K, Madsbad S.

    Diabetes Care. 2002 May;25(5):883-8.PMID: 11978685 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

    Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

    Clin Ther. 2005;27 Suppl B:S57-74. Review.PMID: 16519038 [PubMed - indexed for MEDLINE]Related articles

    3.

    Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.

    Niskanen L, Jensen LE, Råstam J, Nygaard-Pedersen L, Erichsen K, Vora JP.

    Clin Ther. 2004 Apr;26(4):531-40.PMID: 15189750 [PubMed - indexed for MEDLINE]Related articles

    4.

    Biphasic insulin aspart 30: literature review of adverse events associated with treatment.

    Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R.

    Clin Ther. 2005;27 Suppl B:S75-88. Review.PMID: 16519039 [PubMed - indexed for MEDLINE]Related articles

    5.

    Postprandial glycemic control with biphasic insulin aspart in patients with type 1 diabetes.

    Hermansen K, Vaaler S, Madsbad S, Dalgaard M, Zander M, Begtrup K, Soendergaard K.

    Metabolism. 2002 Jul;51(7):896-900.PMID: 12077738 [PubMed - indexed for MEDLINE]Related articles

    6.

    Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus.

    McSorley PT, Bell PM, Jacobsen LV, Kristensen A, Lindholm A.

    Clin Ther. 2002 Apr;24(4):530-9.PMID: 12017398 [PubMed - indexed for MEDLINE]Related articles

    7.

    Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.

    Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, Madsbad S.

    Acta Diabetol. 2000 Mar;37(1):41-6.PMID: 10928235 [PubMed - indexed for MEDLINE]Related articles

    8.

    Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.

    Lindholm A, McEwen J, Riis AP.

    Diabetes Care. 1999 May;22(5):801-5.PMID: 10332685 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

    Malone JK, Woodworth JR, Arora V, Yang H, Campaigne BN, Hallé JP, Yale JF, Grossman LD.

    Clin Ther. 2000 Feb;22(2):222-30.PMID: 10743981 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of thrice daily 'high' vs. 'medium' premixed insulin aspart with respect to evening and overnight glycaemic control in patients with type 2 diabetes.

    Ejskjaer N, Rasmussen M, Kamp N, Lindholm A, Christiansen JS.

    Diabetes Obes Metab. 2003 Nov;5(6):438-45.PMID: 14617230 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of a fixed mixture of 25% insulin lispro and 75% NPL on plasma glucose during and after moderate physical exercise in patients with type 2 diabetes.

    Herz M, Profozic V, Arora V, Smircic-Duvnjak L, Kovacevic I, Boras J, Campaigne BN, Metelko Z.

    Curr Med Res Opin. 2002;18(4):188-93.PMID: 12201618 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

    Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

    Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.

    Maggs DG, Fineman M, Kornstein J, Burrell T, Schwartz S, Wang Y, Ruggles JA, Kolterman OG, Weyer C.

    Diabetes Metab Res Rev. 2004 Jan-Feb;20(1):55-60.PMID: 14737746 [PubMed - indexed for MEDLINE]Related articles

    14.

    Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.

    Feinglos MN, Thacker CH, English J, Bethel MA, Lane JD.

    Diabetes Care. 1997 Oct;20(10):1539-42.PMID: 9314631 [PubMed - indexed for MEDLINE]Related articles

    15.

    Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.

    Roach, Koledova E, Metcalfe S, Hultman C, Milicevic Z; Romania/Russia Mix25 Study Group.

    Clin Ther. 2001 Oct;23(10):1732-44.PMID: 11726007 [PubMed - indexed for MEDLINE]Related articles

    16.

    Using continuous glucose monitoring to measure the frequency of low glucose values when using biphasic insulin aspart 30 compared with biphasic human insulin 30: a double-blind crossover study in individuals with type 2 diabetes.

    McNally PG, Dean JD, Morris AD, Wilkinson PD, Compion G, Heller SR.

    Diabetes Care. 2007 May;30(5):1044-8. Epub 2007 Feb 2.PMID: 17277042 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes.

    Malone JK, Yang H, Woodworth JR, Huang J, Campaigne BN, Halle JP, Yale JF, Grossman LD.

    Diabetes Metab. 2000 Dec;26(6):481-7.PMID: 11173719 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

    Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

    Clin Ther. 2007 Nov;29(11):2374-84.PMID: 18158078 [PubMed - indexed for MEDLINE]Related articles

    19.

    A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

    Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, Hirschberger S, Pieber TR.

    Diabetes Care. 2002 Nov;25(11):2053-7.PMID: 12401756 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

    Koivisto VA, Tuominen JA, Ebeling P.

    Diabetes Care. 1999 Mar;22(3):459-62.PMID: 10097929 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...